Analystreport

VBI Vaccines (NASDAQ: VBIV) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $13.00 price target on the stock, up previously from $11.00.

VBI Vaccines, Inc. - Ordinary Shares  (VBIV) 
Last vbi vaccines, inc. - ordinary shares earnings: 11/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: vbivaccines.com/investors